IL-15 Mediates Anti-tumor Effects after Cyclophosphamide Injection of Tumor-Bearing Mice and Enhances Adoptive Immunotherapy: The Potential Role of NK Cell Subpopulations

This publication has 24 references indexed in Scilit:

• Studies Evaluating the Antitumor Activity and Toxicity of Interleukin-15, a New T Cell Growth Factor: Comparison with Interleukin-2
  Cellular Immunology, 1995
• Chemoattraction of human blood T lymphocytes by interleukin-15.
  Journal of Experimental Medicine, 1995
• Interleukin-15 and the Growth of Tumor Derived Activated T-Cells
  Cancer Biotherapy, 1995
• Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
  Journal of Experimental Medicine, 1994
• Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor
  Science, 1994
• Qualitative and quantitative intratumoral changes in gene expression following cyclophosphamide injection and the adoptive transfer of t cells: The potential contribution of tumor-associated macrophages
  International Journal of Cancer, 1994
• The biological effects of immunosuppression on cellular immunotherapy
  Surgical Oncology, 1992
• Differentialin situ expansion and gene expression of CD4+ and CD8+ tumor-infiltrating lymphocytes following adoptive immunotherapy in a murine tumor model system
  European Journal of Immunology, 1991
• Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells.
  Journal of Experimental Medicine, 1988
• Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.
  Journal of Experimental Medicine, 1982